Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Main Objective of This Study is to Evaluate the Virologic Effectiveness at M6 of Regimen Containing Raltegravir in Treatment Naive HIV Subtype Non B or B Infected Subjects

NCT01162538 is registered in ClinicalTrials.gov with Centre Hospitalier Intercommunal Robert Ballanger as lead sponsor.

NCT NCT01162538
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01162538 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Main Objective of This Study is to Evaluate the Virologic Effectiveness at M6 of Regimen Containing Raltegravir in Treatment Naive HIV Subtype Non B or B Infected Subjects
Lead sponsor
Centre Hospitalier Intercommunal Robert Ballanger
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2010
Completion date
March 31, 2012
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

evaluated, naive patients, non b subtype